The Third People's Hospital of Chengdu

Chengdu 610014

3 studies enrolling now · 3 studies all time

What they study most

Metastatic Castration-resistant Prostate Neoplasms, Non-Muscle Invasive Bladder Neoplasms, Prostatic Neoplasms, Castration-Resistant

Studies at this site

• A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer — Recruiting now
• A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) — Recruiting now
• A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer — Recruiting now